|
|
|
|
|
|||
|
|||
 |
   |
 |
    |
 |
 |
||||
|
Bacterin International develops novel anti-infective coatings based on proprietary knowledge of the physiological changes made by microbes as they sense and adapt to changes in their environment. We manufacture and license bioactive coatings for medical applications. As an early-stage, rapidly growing company, our current priorities are biofilm inhibition, drug delivery and anti-thrombotic factors for medical device coatings. Bacterin International has established a biologic division to leverage it's intellectual coating technologies. It is Bacterin's vision that allografts can be enhanced by coating technologies for the delivery of growth factors, proteins, or therapeutic agents to the surgical site. Through the application of efficacious coatings for devices and biologics, Bacterin will provide innovative, safe, reliable, and cost-effective solutions for the needs of medical practitioners and their patients.
|
|
